Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

被引:179
|
作者
Cheung, Alfred K. [1 ]
Chang, Tara, I [2 ]
Cushman, William C. [3 ]
Furth, Susan L. [4 ,5 ]
Hou, Fan Fan [6 ]
Ix, Joachim H. [7 ,8 ]
Knoll, Gregory A. [9 ]
Muntner, Paul [10 ]
Pecoits-Filho, Roberto [11 ,12 ]
Sarnak, Mark J. [13 ]
Tobe, Sheldon W. [14 ,15 ]
Tomson, Charles R., V [16 ]
Lytvyn, Lyubov [17 ,18 ]
Craig, Jonathan C. [19 ,20 ]
Tunnicliffe, David J. [20 ,21 ]
Howell, Martin [20 ,21 ]
Tonelli, Marcello [22 ]
Cheung, Michael [23 ]
Earley, Amy [23 ]
Mann, Johannes F. E. [24 ,25 ]
机构
[1] Univ Utah Hlth, Dept Internal Med, Div Nephrol & Hypertens, Salt Lake City, UT USA
[2] Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94304 USA
[3] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA
[4] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[5] Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA
[6] Southern Med Univ, Nanfang Hosp, Div Nephrol, Guangzhou, Guangdong, Peoples R China
[7] Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, San Diego, CA 92103 USA
[8] Vet Affairs San Diego Healthcare Syst, Nephrol Sect, La Jolla, CA USA
[9] Univ Ottawa, Ottawa Hosp, Dept Med, Ottawa, ON, Canada
[10] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA
[11] Arbor Res Collaborat Hlth, Ann Arbor, MI USA
[12] Pontificia Univ Catolica Parana, Sch Med, Curitiba, Parana, Brazil
[13] Tufts Med Ctr, Dept Med, Div Nephrol, Boston, MA 02111 USA
[14] Univ Toronto, Dept Med, Div Nephrol, Toronto, ON, Canada
[15] Northem Ontario Sch Med, Sudbury, ON, Canada
[16] Newcastle Upon Tyne Hosp NHS Trust, Freeman Hosp, Newcastle Upon Tyne, Tyne & Wear, England
[17] MAGIC Evidence Ecosyst Fdn, Hamilton, ON, Canada
[18] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[19] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia
[20] Cochrane Kidney & Transplant, Sydney, NSW, Australia
[21] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia
[22] Univ Calgary, Calgary, AB, Canada
[23] KDIGO, Brussels, Belgium
[24] KfH Kidney Ctr, Isoldenst 15, DE-80804 Munich, Germany
[25] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany
基金
美国国家卫生研究院;
关键词
albuminuria; ambulatory blood pressure monitoring; angiotensin-converting enzyme inhibitor; angiotensin II receptor blocker; anti-hypertensive agents; automated office blood pressure; blood pressure measurement; blood pressure targets; children; chronic kidney disease; creatinine; diabetes; dietary sodium; evidence-based; guideline; home blood pressure monitoring; hyperkalemia; KDIGO; kidney transplant recipient; lifestyle; mineralocorticoid receptor antagonist; office blood pressure; physical activity; potassium; proteinuria; renin-angiotensin system; standardized office blood pressure; systematic review; weight loss; CARDIOVASCULAR OUTCOMES; RENAL-FAILURE; PROGRESSION; HYPERTENSION; PREVENTION; BENAZEPRIL; ADULTS; TRIAL; RISK;
D O I
10.1016/j.kint.2020.10.026
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease for patients not receiving dialysis represents an update to the KDIGO 2012 guideline on this topic. Development of this guideline update followed a rigorous process of evidence review and appraisal. Guideline recommendations are based on systematic reviews of relevant studies and appraisal of the quality of the evidence. The strength of recommendations is based on the "Grading of Recommendations Assessment, Development and Evaluation" (GRADE) approach. The scope includes topics covered in the original guideline, such as optimal blood pressure targets, lifestyle interventions, antihypertensive medications, and specific management in kidney transplant recipients and children. Some aspects of general and cardiovascular health, such as lipid and smoking management, are excluded. This guideline also introduces a chapter dedicated to proper blood pressure measurement since all large randomized trials targeting blood pressure with pivotal outcomes used standardized preparation and measurement protocols adhered to by patients and clinicians. Based on previous and new evidence, in particular the Systolic Blood Pressure Intervention Trial (SPRINT) results, we propose a systolic blood pressure target of less than 120 mm Hg using standardized office reading for most people with chronic kidney disease (CKD) not receiving dialysis, the exception being children and kidney transplant recipients. The goal of this guideline is to provide clinicians and patients a useful resource with actionable recommendations supplemented with practice points. The burden of the recommendations on patients and resources, public policy implications, and limitations of the evidence are taken into consideration. Lastly, knowledge gaps and recommendations for future research are provided.
引用
收藏
页码:559 / 569
页数:11
相关论文
共 50 条
  • [21] Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease'
    Andrassy, Konrad M.
    [J]. KIDNEY INTERNATIONAL, 2013, 84 (03) : 622 - 623
  • [22] KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD
    Drawz, Paul E.
    Beddhu, Srinivasan
    Bignall, O. N. Ray, II
    Cohen, Jordana B.
    Flynn, Joseph T.
    Ku, Elaine
    Rahman, Mahboob
    Thomas, George
    Weir, Matthew R.
    Whelton, Paul K.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (03) : 311 - 327
  • [23] Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis
    Floege, Juergen
    Jayne, David R. W.
    Sanders, Jan-Stephan F.
    Tesar, Vladimir
    Balk, Ethan M.
    Gordon, Craig E.
    Adam, Gaelen
    Tonelli, Marcello A.
    Cheung, Michael
    Earley, Amy
    Rovin, Brad H.
    [J]. KIDNEY INTERNATIONAL, 2024, 105 (03) : 447 - 449
  • [24] Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update
    Navaneethan, Sankar D.
    Zoungas, Sophia
    Caramori, M. Luiza
    Chan, Juliana C. N.
    Heerspink, Hiddo J. L.
    Hurst, Clint
    Liew, Adrian
    Michos, Erin D.
    Olowu, Wasiu A.
    Sadusky, Tami
    Tandon, Nikhil
    Tuttle, Katherine R.
    Wanner, Christoph
    Wilkens, Katy G.
    Craig, Jonathan C.
    Tunnicliffe, David J.
    Tonelli, Marcello
    Cheung, Michael
    Earley, Amy
    Rossing, Peter
    de Boer, Ian H.
    Khunti, Kamlesh
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (03) : 381 - 387
  • [25] Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States
    Foti, Kathryn E.
    Wang, Dan
    Chang, Alexander R.
    Selyin, Elizabeth
    Sarnak, Mark J.
    Chang, Tara, I
    Muntner, Paul
    Coresh, Josef
    [J]. KIDNEY INTERNATIONAL, 2021, 99 (03) : 686 - 695
  • [26] Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease' Reply
    Levin, Adeera
    Stevens, Paul E.
    [J]. KIDNEY INTERNATIONAL, 2013, 84 (03) : 623 - 623
  • [27] Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation
    Chadban, Steven J.
    Ahn, Curie
    Axelrod, David A.
    Foster, Bethany J.
    Kasiske, Bertram L.
    Kher, Vijah
    Kumar, Deepali
    Oberbauer, Rainer
    Pascual, Julio
    Pilmore, Helen L.
    Rodrigue, James R.
    Segev, Dorry L.
    Sheerin, Neil S.
    Tinckam, Kathryn J.
    Wong, Germaine
    Balk, Ethan M.
    Gordon, Craig E.
    Earley, Amy
    Rofeberg, Valerie
    Knoll, Gregory A.
    [J]. TRANSPLANTATION, 2020, 104 (04) : 708 - 714
  • [28] Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?
    Wheeler, David C.
    Becker, Gavin J.
    [J]. KIDNEY INTERNATIONAL, 2013, 83 (03) : 377 - 383
  • [29] KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
    Kasiske, Bertram L.
    Zeier, Martin G.
    Chapman, Jeremy R.
    Craig, Jonathan C.
    Ekberg, Henrik
    Garvey, Catherine A.
    Green, Michael D.
    Jha, Vivekanand
    Josephson, Michelle A.
    Kiberd, Bryce A.
    Kreis, Henri A.
    McDonald, Ruth A.
    Newmann, John M.
    Obrador, Gregorio T.
    Vincenti, Flavio G.
    Cheung, Michael
    Earley, Amy
    Raman, Gowri
    Abariga, Samuel
    Wagner, Martin
    Balk, Ethan M.
    [J]. KIDNEY INTERNATIONAL, 2010, 77 (04) : 299 - 311
  • [30] KHA-CARI commentary on the KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease
    Palmer, Suetonia C.
    Strippoli, Giovanni F. M.
    Craig, Jonathan C.
    [J]. NEPHROLOGY, 2014, 19 (11) : 663 - 666